Pure Global

The second generation of the Roche EGFR Gene Mutation Test Kit - Taiwan Registration c45ff11208cdb8a3c2f84700831a3626

Access comprehensive regulatory information for The second generation of the Roche EGFR Gene Mutation Test Kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number c45ff11208cdb8a3c2f84700831a3626 and manufactured by Roche Molecular Systems, Inc.;; ROCHE DIAGNOSTICS GMBH. The authorized representative in Taiwan is ROCHE DIAGNOSTICS LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
c45ff11208cdb8a3c2f84700831a3626
Registration Details
Taiwan FDA Registration: c45ff11208cdb8a3c2f84700831a3626
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

The second generation of the Roche EGFR Gene Mutation Test Kit
TW: ็พ…ๆฐEGFRๅŸบๅ› ็ช่ฎŠๆชข้ฉ—ๅฅ—็ต„็ฌฌไบŒไปฃ
Risk Class 3

Registration Details

c45ff11208cdb8a3c2f84700831a3626

DHA05602893508

Company Information

Product Details

This product is an instant PCR detection reagent, targeting the DNA of human non-small cell lung cancer (NSCLC) tumor tissue with formalin-fixed paraffin-embedded (FFPET) or the epidermal growth factor receptor (EGFR) gene exon 18, 19, and plasma of human non-small cell lung cancer (NSCLC) patients. Mutations of 20 and 21 are qualitatively detected and identified. This test can assist in the selection of human non-small cell lung cancer (NSCLC) patients who can be treated with EGFR tyrosine kinase inhibitor (TKI). This product is used in plasma to further semi-quantitatively measure EGFR gene 18, 19, 20 and 21 mutations in human plasma collected over a period of time, and to assist in the management of human non-small cell lung cancer (NSCLC) patients. Formalin-fixed paraffin-embedded (FFPET) samples were treated using the Roche DNA Extraction Kit, while plasma samples were treated with the Roche Free DNA Extraction Kit. This product is used with the Cobas Z 480 analyzer for automated amplification reaction and detection procedures.

B Hematology, pathology, and genetics

B.4020 Analysis of specific tests

import

Dates and Status

Oct 27, 2016

Oct 27, 2026